SOPHARMA AD - Notification for sales revenues for October

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. SFA_Sales_Revenues_October_2025_EN_espi.pdfNotification for sales revenues for October
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 224 / 2025

Date of issue: 2025-11-20

Short name of the issuer

SOPHARMA AD

Subject

Notification for sales revenues for October

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, November 20, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for October 2025 the Company recorded increase in sales of 23% compared to the same month of the previous year, incl. 15% increase in domestic sales and 26% increase in export sales.
For the period from the beginning of 2025, the Company realized a 9% increase in sales, including maintaining the level of sales on the domestic market and a 16% increase in export sales.

Annexes

File Description

SFA_Sales_Revenues_October_2025_EN_espi.pdfSFA_Sales_Revenues_October_2025_EN_espi.pdf Notification for sales revenues for October

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2025-11-20 Ognian Ivanov Donev Executive Director